Sie sind auf Seite 1von 3

TENTATIVE BALI ENDOCRINE UPDATE (BEU) XIV

Workshop Hypoglicaemia
Waktu Workshop. Friday, April 21 th 2017
(WITA)
08.00 – 08.30 Opening Ceremony
WITA (30 Menit)
08.30 – 09.30 Materi 1 :Hypoglycemia risk in DM Management
WITA (60 Menit) Prof. Dr. dr. Ketut Suastika, Sp.PD-KEMD
09.30 – 10.30 Materi 2 :DPP4 Inhibitor Therapy in DM Management Focus in Hypoglycemia Risk
WITA (60 Menit) Dr. dr. Made Ratna Saraswati, Sp.PD-KEMD
10.30 – 11.00 Rehat Cofee Break
WITA (30 Menit)
11.00 – 12.30 Case Discussion
WITA (45 Menit) Moderator: dr. I Made Pande Dwipayana, Sp.PD-KEMD
12.30 – 12.45 Closing End of Workshop
WITA (15 Menit)
12.45 - end Lunch

Workshop Diabetic Foot


Waktu Workshop. Friday, April 21 th 2017
(WITA)
08.00 – 08.30 Opening Ceremony
WITA (30 Menit)
08.30 – 09.30 Materi 1 : Diabetic Foot Patophysiology
WITA (60 Menit) Dr dr Wira Gotera SpPD KEMD
09.30 – 10.30 Materi 2 : Examination and Management of Diabetic Foot
WITA (60 Menit) dr I Made Siswadi Sp.PD , M Biomed
10.30 – 11.00 Rehat Cofee Break
WITA (30 Menit)
11.00 – 12.30 Hands on Patient : Examination and Management of Diabetic Foot
WITA (45 Menit) Ns Putu Adi Mediawati
12.30 – 12.45 Closing End of Workshop
WITA (15 Menit)
12.45 - end Lunch
TIME (WITA) Day 1. Saturday, April 22 th 2017
08.00 – 08.15 Opening Ceremony
WITA (15 Menit)
08.15 – 08.45 Plenary Lecture 1
WITA (30 Menit) Optimizing and Advancing Basal Insulin.
Adressing Unmet Clinical Needs With Basal Insulin Therapy: A New Insight
Speaker : Prof. Dr. dr. Ketut Suastika, Sp.PD-KEMD
08.45 – 09.30 Morning Sympo
WITA (45 Menit) Topic: CV Risk and T2DM : New Insight and Outcomes in Treatment Options
1. SGLT-2 Inhibition : Addresing the core defects of T2DM
Speaker : Prof. Dr. dr. Ketut Suastika, Sp.PD-KEMD
2. Paradigm Shift in T2DM Therapy-Beyond Glicemic Control
Speaker I : Dr. dr. Made Ratna Saraswati, Sp.PD-KEMD
Moderator : Dr. dr. Wira Gotera, Sp.PD-KEMD
09.30 – 10.00 Coffee break
WITA (30 Menit)
10.00 – 10.45 Pre-Lunch Symposium 1
WITA (45 Menit) 1. Management of oral antidiabetic in type 2 DM management as PERKENI guideline.
Speaker I : Dr. dr. Made Ratna Saraswati, Sp.PD-KEMD
2. Combination of insulin and vidaglipitin to reduce risk of hypoglycemic event.
Speaker II : Dr. dr. Wira Gotera, Sp.PD-KEMD
Moderator : dr I Made Siswadi Sp.PD , M Biomed
10.45 – 11.45 Lunch Symposium 1
WITA (60 Menit) Topic: Insulin Therapy: Practical Case on Initiation and Intensification
1. Insulin Initiation : Premix or Long Acting Insulin ?
Speaker I : dr. Sony Wibisono, SpPD-KEMD
2. Insulin Intensification : When simple Injection Does not control Blood Glucose.
Speaker II : Dr. dr. Wira Gotera, Sp.PD-KEMD
Moderator : dr. I Made Pande Dwipayana, Sp.PD-KEMD
11.45 – 12.45 Lunch
WITA (60 Menit)
12.45 – 13.30 Post-Lunch Symposium 1
WITA (45 Menit) Topic: Management of Anemia in Diabetic Nephropathy
1. Diabetic Nephropathy and complication
Speaker: Prof. Dr. dr. Ketut Suastika, Sp.PD-KEMD
2. Benefit of early correction renal anemia
Speaker: Dr. dr. Made Ratna Saraswati, Sp.PD-KEMD
Moderator : dr. Dewi Catur Wulandari, SpPD
13.30 – 14.15 Post-Lunch Symposium 2
WITA (45 Menit) 1.Calcium Metabolism and Disorder
Speaker I : Prof. Dr. dr. AAG Budhiarta, Sp.PD-KEMD
2. Cushing Sindrome
Speaker II : dr. I Made Pande Dwipayana, Sp.PD-KEMD
Moderator : dr I Made Siswadi Sp.PD , M Biomed
14.15 – 14.45 Plenary Lecture 2
WITA (30 Menit) Medical Management of Thyroid Nodule
Speaker: Prof. Dr. dr. AAG Budhiarta, SpPD-KEMD
14.45 – 15.00 End of the Day 1
Waktu Day 2. Sunday, April 23 th 2016
(WITA)
08.00-08.30 Plenary Lecture 3
WITA (30 Menit) Endocrine Disruptor
Speaker : Prof. Dr. dr. Ahmad Rudijanto, Sp.PD-KEMD
Moderator : Prof. dr. I N Dwi Sutanegara, SpPD-KEMD
08.30 -09.15 Morning Sympo 2
WITA (45 Menit) 1. Overview of Gut Microbiota
Speaker I : Ir. I Nengah Sujaya, M.AgrSc, Ph.D
2. Gut Microbiota and Metabolic Disorders
Speaker II : dr. Komang Januarta Putra Pinatih, M.Kes
Moderator : dr. Dewi Catur Wulandari, SpPD
09.15-09.45 Coffee break
WITA (30 Menit)
09.45-10.30 Pre-Lunch Symposium 4
WITA (45 Menit) 1. Hypertiroid How Can We Manage it Better?
Speaker I : dr. I Made Pande Dwipayana, Sp.PD-KEMD
2. Is All Anti-Thyroid Drug the Same
Speaker II : dr. Risa Anwar, MD
Moderator : dr I Made Siswadi Sp.PD , M Biomed
10.30-11.30 Lunch Symposium 2
WITA (60 Menit) 1. The Application of TECOS CV Safety Study in Clinical Practice
Speaker I : Dr. dr. Wira Gotera, Sp.PD-KEMD
2. Introducing to Sutagliptin Metformin Extended Release (Janumet XR)
Speaker II : Dr. dr. Putu Moda Arsana, Sp.PD-KEMD
Moderator : dr. I Made Pande Dwipayana, Sp.PD-KEMD
11.30 – 12.30 Lunch
WITA (60 Menit)
12.30 – 13.15 Post-Lunch Symposium 3
WITA (45 Menit) 1. Discover the Clinical Benefits of Liraglutide : A-Patient Centered Approach
Speaker I : dr. I Made Pande Dwipayana, Sp.PD-KEMD
2. Benefits of Once Daily Use of Insulin Detemir in Type 2 DM Management
Speaker II : Dr. dr. AA Budhitresna, Sp.PD-KEMD
Moderator : dr. Dewi Catur Wulandari, SpPD
13.15 – 14.00 Post-Lunch Symposium 4 Obesitas / Endokrin anak
WITA (45 Menit) Short Stature
Speaker I : Dr. dr. Bikin Suryawan Sp.A (K)
Obesitas Pada Anak
Speaker II : dr. I Made Arimbawa, Sp.A (K)
Moderator : dr I Made Siswadi Sp.PD , M Biomed
14.00 – 14.30 Plenary Lecture 4
WITA (30 Menit) Recent Guidelines : Statin Therapy in Dyslipidemia
Speaker : Prof. Dr. dr. Ketut Suastika, Sp.PD-KEMD
Moderator : Prof. dr. I N Dwi Sutanegara, SpPD-KEMD
Closing Ceremony

Das könnte Ihnen auch gefallen